Antique Investor Conference

Jump to

Planning capex of Rs 300 cr at Guwahati plant: Ajanta Pharma

On the sidelines of the Antique Investor Conference, Yogesh Agrawal, Md of Ajanta Pharma told CNBC-TV18 that the company has filed for 5 Abbreviated New Drug Application‘s (ANDA) of which 2 tentative approvals may be launched in the near future.
'If stocks come back in favour globally, India will do well'

Despite the high volatility witnessed in stocks globally, investor sentiment is not as shaken and if equity were to make a comeback, Indian shares are likely to do well, said Amish Shah, VP - Equity Sales, Antique Stock Broking.
Financials to lead, SBI seen biggest beneficiary: Antique

Speaking to CNBC-TV18 on the sidelines of Antique Investor Conference, Kirti Doshi and Dharmesh Dalal said structural changes in economy are seen at grassroots level and may start reflecting in earnings too in the next 2-3 quarters.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Antique Investor Conference

Planning capex of Rs 300 cr at Guwahati plant: Ajanta Pharma

'If stocks come back in favour globally, India will do well'

Financials to lead, SBI seen biggest beneficiary: Antique